Archive

2006 Poster Abstracts

Browse by Title:

A metabolic study of HIF-2 alpha over-expressing and empty vector 7860 renal tumours using in vivo and in vitro 1H MRS

Poster No: B114

Authors:
TROY H, CHUNG Y-L, MADHU B, HARRIS A.L, WIGFIELD S, BISWAS S, STUBBS M, GRIFFITHS J.R

A Microarray Screen Identifies Dll4 Target Genes in Endothelial Cells

Poster No: A205

Authors:
HARRINGTON L.S., SAINSON R.C.A., KIMMEL WILLIAMS C, SHI W, LI J-L, HARRIS A.L.

A New (Bayesian) Classification of Human Breast Cancer

Poster No: C121

Authors:
CAMPBELL C, CARRIVICK L, ROGERS S, CLARK JP, GIROLAMI M, COOPER CS

A prospective study of active surveillance for untreated, localised prostate cancer

Poster No: B33

Authors:
PARKER CC, NORMAN AR, VAN AS N, HORWICH A, HUDDART RA, KHOO VS, THOMPSON A, DEARNALEY DP

A randomised trial of the combination of lomeguatrib and temozolomide and temozolomide alone in patients with advanced melanoma.

Poster No: A138

Authors:
MIDDLETON M, RANSON M, HERSEY P, BEITH J, THOMPSON D, MORTIMER P, MARGISON G

A Study of the Effect of Ethnicity on Prostate Cancer Familiality and Survival of Men with Prostate Cancer in the United Kingdom.

Poster No: B46

Authors:
GUY M, SOUTHGATE C, O'BRIEN L, HALL A, GEHR-SWAIN B, WILKINSON R, NORMAN A, DEARNALEY DP, KHOO VS, PARKER CC, HUDDART RA, HORWICH A, FALCONER A, EELES RA

A STUDY TO ASSESS THE BENEFITS OF COGNITIVE BEHAVIOURAL THERAPY TO MAINTAIN PSYCHOLOGICAL WELL BEING IN A GROUP OF ONCOLOGISTS

Poster No: A25

Authors:
MCKINNA F.E., MARIEN B, BLOOMFIELD D, CHALMERS A, DEUTSCH G, BASSAN J, HIERSCHE A, MITRA S, NEWMAN G, SIMCOCK R, SIMPSON J, WEBB A, WILKINS M, WILLIAMS C

A survey of alternative therapies in chemotherapy patients-cancer centre study

Poster No: A20

Authors:
HATCHER HM, PALMER CA, HORAN G, SIMPSON N, EARL HM

Aberrant CpG island methylation is potentially both an early diagnostic and predictive marker of ovarian cancer

Poster No: BOA6

Authors:
HARDIE C, TEODORIDIS J.M, HALL J, CURTO J, SIDDIQUI N, BROWN R

Accurate prediction of BRCA1 and BRCA2 heterozygous genotype using expression profiling after irradiation induced DNA damage

Poster No: A124

Authors:
KOTE-JARAI Z, MATTHEWS L, OSORIO A, SHANLEY S, GIDDINGS I, LOCKE I, EVANS G, WILLIAMS R, GIROLAMI M, CAMPBELL C, EELES R

Acute toxicity of concomitant temozolamide in glioblastoma: experience of introducing a new treatment strategy to the clinic

Poster No: A167

Authors:
GREGORY DL, HOLLINGDALE AE, BURTON KE, JONES PH, BURNET NG, JEFFERIES SJ

AIDIT and IMPACT: strengthening research ties in Eastern Europe

Poster No: A115

Authors:
DOHERTY R, LUBINSKI J, ZIEBA K, MANGUOGLU E, LULECI G, CHRISTIE M, BANCROFT E, MITRA A, MORGAN S, EELES R

Amphiphilic hypercoiling polymer mediated delivery of novel cytotoxics

Poster No: CR-UK5

Authors:
TAVASSOLI M, FARZANEH F, SLATER N, LUXON B

Amplification and gain of MDM4, a p53 regulator in urothelial cell carcinoma

Poster No: A89

Authors:
VEERAKUMARASIVAM A, SCOTT H E, WALLARD M J, WHITAKER H C, MILLS I G, ICHIMURA K, LEUNG H Y, COLLINS V P, NEAL D E, KELLY J D

An investigation of the in vitro and in vivo pharmacology of a selective inhibitor of Aurora B kinase (AZD1152) in AML

Poster No: A214

Authors:
OKE A, PEARCE D, CRAFTER C, KEEN N, MUNDT K, ODEDRA R, WILKINSON RW, FOOT N, LISTER A, BONNET D, FITZGIBBON J, JOEL S

Analysis of the isochromosome 17q breakpoint in medulloblastomas

Poster No: C75

Authors:
MCCABE MG, LIU L, PEARSON DM, ICHIMURA K, ELLISON DW, CLIFFORD SC, COLLINS VP

ANDROGEN REGULATION OF GONADOTROPIN RELEASING HORMONE TYPE II IN PROSTATE CANCER

Poster No: B24

Authors:
DARBY S, STOCKLEY J, ROBSON CN, EDMONSON RJ, LEUNG HY, GNANAPRAGASAM VJ

Antisense RNA and DNA Methylation in Cancer

Poster No: C18

Authors:
CRUICKSHANKS H A, HASTINGS R K, BADGE R M, TUFARELLI C

Applying a new paradigm of epidermal homeostasis to analyse the clonal evolution of cancer

Poster No: CR-UK11

Authors:
CLAYTON E, SIMONS B D, DOUPE D, WINTON D J, JONES P H

Are post-mortems in caner patients useful?

Poster No: A18

Authors:
HALL PS, BAVIDGE KL, CAREY F, RANKIN EM

ASPECTS: A Study of Patients Experiences of TreatmentS

Poster No: A15

Authors:
AUDREY S, BLAZEBY J, ABEL J, CAMPBELL R

Aspirin Induces Activation of NFkB Signalling and Apoptosis in Rectal Cancer Patients

Poster No: B71

Authors:
DIN FVN, REID K, MACDONALD AD, BRADY R, DUNLOP MG, STARK LA

Assessing response to Transarterial Embolisation for HCC: A comparison of RECIST, EASL and AFP criteria.

Poster No: A59

Authors:
WOODWARD N, DAVIES N, PAPADOPOLOU A, BALLESFIN-SKELTON M, BURROUGHS A, MEYER T

Assessment of hypoxia associated markers in oesophagogastric cancer

Poster No: A53

Authors:
GRIFFITHS EA, PRITCHARD SA, WELCH IM, BISHOP PW, PRICE PM, WEST C

Assessment of patient-scored normal tissue outcomes of prostate brachytherapy

Poster No: BOA8

Authors:
ANANDADAS C, ROUTLEDGE J, MANDALL P, SWINDELL R, LOGUE J, WYLIE J, DAVIDSON S

Association between lung cancer risk and single nucleotide polymorphisms in the first intron and codon 178 of the DNA Repair gene O6-alkylguanine-DNA alkyltransferase

Poster No: A130

Authors:
POVEY AC, CROSBIE PAJ, PEARSON SJ, MCGOWN G, THORNCROFT MR, WATSON AJ, O'DONNELL PNS, BARBER PV, LEWIS SJ, HARRISON KL, AGIUS RM, DONNELLY D, MCELHINNEY RS, MCMURRY BH, SANTIBANEZ-KOREF MF, MARGISON GP

Association of topoisomerase-1 (Topo1) with the efficacy of chemotherapy in a randomized trial for advanced colorectal cancer patients (FOCUS).

Poster No: BOA15

Authors:
BRAUN M.S., RICHMAN S.D., ADLARD J.W., DALY C., TURNER F., BARRETT J., PARMAR M., SELBY P., QUIRKE P., SEYMOUR M.T.

Atl-1 protects S.pombe against the toxic effects of O6-alkylguanine in DNA

Poster No: A133

Authors:
WATSON A.J., BEGUM G., BUTT A., WHARTON S., PEARSON S.J., MARRIOTT A., WILLIAMS D., SHIBATA T., SANTIBANEZ-KOREF M., MARGISON G.P.

ATM mutations occur in multiple myeloma at a low frequency

Poster No: A101

Authors:
AUSTEN B, BARONE C, RIEMAN A, BYRD P, BAKER C, STARCZYNSKI J, ENRIGHT H, QUINN J, PRATT G, STANKOVIC T, TAYLOR A

Attending the general practitioner for routine melanoma follow-up: the practical experiences of participants in an RCT

Poster No: A65

Authors:
MURCHIE PETER, CAMPBELL NEIL, HANNAFORD PHILIP, NICOLSON MARIANNE, WYKE SALLY

Aurora kinase inhibitors identified using a fragment-based drug discovery approach.

Poster No: A193

Authors:
CURRY J, ANGOVE H, BERDINI V, CARR M, FAZAL L, HOWARD S, LYONS J, MAMAN S, REULE M, TISI D, GILL A

AZD1152, a novel Aurora kinase inhibitor induces endoreduplication, polyploidy and apoptosis leading to profound antitumour effects in multiple tumour xenograft models

Poster No: A213

Authors:
ODEDRA R, HEATON SP, CRAFTER C, KEEN N, WEDGE SR, MUNDT K, FOOTE KM, BRADY MC, FOSTER JJ, GREEN S, WILKINSON R

AZD2171 inhibits VEGF receptor-2 signalling and neovascular survival in human tumour xenografts

Poster No: A211

Authors:
SMITH NR, JAMES NH, WAINWRIGHT A, COPLEY C, OAKLEY I, KENDREW J, JURGENSMEIER JM, WEDGE SR, BARRY ST

AZD6244 (ARRY-142886): Preclinical and early clinical development of a potent, selective inhibitor of MEK1/2 kinases

Poster No: A223

Authors:
SMITH P, DAVIES B, WALLACE E, YEH T, LOGIE A, COCKERILL M, HICKINSON M, CANTARINI M, ECKHARDT SG, ADJEI AA, MORRIS C

<<< Return to Abstract Menu

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon Sign up for the NCRI Conference Newsletter
Conference News
09/08/2010
Deadline now extended to 22 August for late breaking abstract submission
08/07/2010
Late breaking abstract submission now open: deadline Monday 9 August
01/06/2010
Online registration is now open
19/04/2010
BOA/Pfizer Excellence in Oncology Awards 2010 now open for entry
22/03/2010
Abstract submission for the 2010 NCRI Cancer Conference is now open. Submit your abstract online.
05/10/2009
View the 2009 abstracts online
03/10/2009
Read press releases from the 2009 NCRI Cancer Conference
29/01/2009
View videos from the 2009 Conference
Subscribe to this newsfeed